Surgical Versus Non-surgical Treatment of Displaced Proximal Humerus Fracture in Adults Aged 50 to 65 Years
PHF50-65
1 other identifier
interventional
60
2 countries
2
Brief Summary
The goal of this clinical trial is to study whether surgery results in better functional outcomes than non-surgical treatment among patients aged 50-65 with a displaced proximal humerus fracture. The main questions it aims to answer are:
- Does osteosynthesis result in better patient-reported functional outcomes compared to non-surgical treatment at 12 months follow-up? Aim is also to characterize the patient group aged 50-65 regarding fracture morphology, osteoporosis, and clinical frailty scale. The study compare operation with either plate or nail fixation to non-surgical treatment. Participants will:
- Receive either surgical treatment or non-surgical treatment.
- At 6 months, 1 year, and 2 years, the patient will answer two short questionnaires (Oxford Shoulder Score and Eq-5D-3L). The primary outcome will be Oxford Shoulder Score at 12 months. The secondary outcome will be OSS at 6 and 24 months and EQ-5D-3L score measured at the same time-points. Adverse events and conversion to surgery will be registered. OSS and EQ-5D-3L will be completed just before the 6 months visit.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2024
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 8, 2024
CompletedStudy Start
First participant enrolled
May 15, 2024
CompletedFirst Posted
Study publicly available on registry
May 16, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
September 18, 2025
September 1, 2025
3.6 years
May 8, 2024
September 11, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Oxford Shoulder Score 12 months
Oxford Shoulder Score is a patient-reported shoulder-specific outcome measure. It is a patient-administrated questionnaire to assess shoulder function. It consists of 12 questions on a 5-point Likert scale (both pain- and function-related), each offering five ordinal response options. The cumulative score ranges between 0 and 48, being 0 (worst) to 48 (best: no pain or no functional limitation).
12 months
Secondary Outcomes (4)
Oxford Shoulder Score
6 and 24 months
EQ-5D-3L
6, 12 and 24 months
Conversion to surgery after inclusion, or additional surgery
24 months
Adverse events.
24 months
Study Arms (2)
Non-surgical treatment
EXPERIMENTALPatients in the non-surgical group will be offered an optional sling for comfort for an additional 1-2 weeks at their first visit,
Procedure: Surgical treatment
ACTIVE COMPARATORThe surgical group will receive osteosynthesis with a locking plate or an intramedullary locking nail, according to the surgeon's choice
Interventions
Surgical group: After osteosynthesis, they will be provided with a sling and swathe immediately after the surgery. From the first postoperative day, only the sling will be used. Two weeks postoperatively, patients will undergo clinical and radiological follow-up in the outpatient clinic. They will be referred to post-operative rehabilitation in the municipalities. At 12 weeks postoperatively, patients will have another clinical and radiological follow-up. This is the current standard care for surgical treatment with a plate or intramedullary nail.
Non-surgical group: Patients in the non-surgical group will be offered an optional sling for comfort for an additional 1-2 weeks at their first visit, 10-14 days post-injury. Patients will be referred to rehabilitation in the municipalities. At week 6 post-injury, all patients will undergo clinical and radiological follow-up. This represents the current standard care for non-surgical treatment of displaced PHF at the departments.
Eligibility Criteria
You may qualify if:
- Patients aged between 50 and 65 years with a displaced PHF assessed to be constructible by the treating surgeon after a low-energy trauma will be considered for eligibility.
- Patients should be cognitively capable of answering the follow-up questionnaires.
You may not qualify if:
- The patient does not understand written and spoken native language (Danish or Finnish/Swedish)
- Inability to give informed consent
- Fractures assessed to be unreconstructedly by the treating surgeon
- Isolated tuberosity fracture, fracture dislocations, open fractures, and fractures with involvement of the articular surface
- Less than 25% contact between head fragment and metaphysis/diaphysis measured at two perpendicular radiographs at two weeks.
- Pathological fractures or previous fractures in the same proximal humerus
- Concomitant fractures, which could influence the outcome
- Paralysis in upper extremity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zealand University Hospitallead
- Tampere University Hospitalcollaborator
Study Sites (2)
Centre for Evidence-Based Orthopaedics, Zealand University Hospital
Køge, Region Sjælland, 4600, Denmark
Tampere University Hospital
Tampere, 33520, Finland
Related Publications (5)
Handoll HH, Elliott J, Thillemann TM, Aluko P, Brorson S. Interventions for treating proximal humeral fractures in adults. Cochrane Database Syst Rev. 2022 Jun 21;6(6):CD000434. doi: 10.1002/14651858.CD000434.pub5.
PMID: 35727196BACKGROUNDAlispahic N, Brorson S, Bahrs C, Joeris A, Steinitz A, Audige L. Complications after surgical management of proximal humeral fractures: a systematic review of event terms and definitions. BMC Musculoskelet Disord. 2020 May 26;21(1):327. doi: 10.1186/s12891-020-03353-8.
PMID: 32456631BACKGROUNDBrorson S, Alispahic N, Bahrs C, Joeris A, Steinitz A, Audige L. Complications after non-surgical management of proximal humeral fractures: a systematic review of terms and definitions. BMC Musculoskelet Disord. 2019 Feb 23;20(1):91. doi: 10.1186/s12891-019-2459-6.
PMID: 30797232BACKGROUNDAudige L, Brorson S, Durchholz H, Lambert S, Moro F, Joeris A. Core set of unfavorable events of proximal humerus fracture treatment defined by an international Delphi consensus process. BMC Musculoskelet Disord. 2021 Nov 30;22(1):1002. doi: 10.1186/s12891-021-04887-1.
PMID: 34847888BACKGROUNDHoukjaer L, Launonen AP, Sumrein BO, Karna L, Issa Z, Holtz KB, Brorson S. Surgical versus non-surgical treatment of proximal humerus fracture in patients aged 50-65 years: young shoulder CARE (displaCed proximAl humeRus fracturE) trial-a pragmatic randomized controlled trial study protocol. Trials. 2025 Dec 29;26(1):588. doi: 10.1186/s13063-025-09283-x.
PMID: 41466383DERIVED
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Line Løjbert Houkjær, M.D.
Center for evidensbaseret ortopædkirurgi, Sjællands Universitets Hospital, Køge.
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The primary investigator will conduct the blinded statistical analysis through data anonymization and will be supervised by a biostatistician. After the blinded statistical analysis has been completed, two abstracts will be written based on the pre-blinding analysis results before the blinding is revealed.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, M.D.
Study Record Dates
First Submitted
May 8, 2024
First Posted
May 16, 2024
Study Start
May 15, 2024
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2028
Last Updated
September 18, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share
No individual participant data (IPD) available to other researchers.